Danaher Teams With NVIDIA to Integrate AI Into Scientific Lab Instruments

Danaher announced on October 14 that it is collaborating with NVIDIA to integrate AI and computing into its scientific instruments and laboratory workflows, following its October 7 announcement of a planned AI-powered autonomous laboratory at its Abcam unit expected to operate at scale in early 2027. For that separate Abcam autonomous lab, Danaher is targeting up to an 8x acceleration in affinity reagent discovery and up to a 10x increase in annual reagent generation, moving from tens to hundreds as operations scale, though those figures remain company targets rather than reported operating results. Initial work under the NVIDIA collaboration will focus on selected priority instruments before potential expansion across Danaher's portfolio, with technologies under consideration including DGX Spark for instrument-level computing, RAPIDS for data processing, BioNeMo Open Models, Cosmos world models, and Omniverse digital twins. Danaher stated that customers will retain choice over models, standards, and technology providers, while the announcement did not disclose financial terms or a commercial rollout schedule. The earlier Abcam laboratory project draws on technologies from Beckman Coulter Life Sciences, Cytiva, Genedata, Integrated DNA Technologies, and Molecular Devices, alongside robotic automation and device orchestration from Automata.